2 nd ESTRO Forum 2013 S205 Conclusions: The results of this study suggest that increasing spinal instability, as defined by the SINS score, is associated with radiotherapy failure. Therefore, patients with (potentially) unstable painful spinal metastases should be considered for surgical stabilization first.
Purpose/Objective: Elderly patients with cancer represent a different population compared to younger patients. Comorbidity and declining performance may result in lesser outcome after palliative treatments. Our goal was to study the effect of age on response to radiotherapy and quality of life in patients with painful bone metastases. Materials and Methods: A large randomized radiotherapy trial showed equal effectiveness in pain relief of 8 Gy in a single fraction compared to 24 Gy in six fractions in patients with painful bone metastases. Between March 1996 and Sept 1998 1157 patients were included. At baseline and regular follow-up, patients completed questionnaires involving, among others, pain on an 11-point scale, several aspects of quality of life (QoL) (psychological distress, physical symptom distress, activity level impairment) and a verbally rated validation of QoL, all items derived from the Rotterdam Symptom Checklist. A visual analogue score (VAS) of QoL was added. Response was calculated conform international standards. Patients were grouped into three agecohorts: A: 32-64 (n=520), B: 65-74 (n=410) and C: ≥ 75 years (n=227). For categorical variables, χ-square was used, for continuous variables, one-way ANOVA, with Bonferroni post-hoctesting. For survival and response analyses, the Kaplan Meier method and Cox-regression were used. Results: At baseline, visually and verbally rated QoL and QoLsumscores were available in 92%, 94% and 94% respectively. Elderly patients had worse performance at inclusion (Karnofsky Performance Score 20-60: 26%(A), 29%(B), 39%(C), p=0.004). When assessing baseline QoL in different age groups, a difference in activity level was noticed (p<0.001, table 1), with significantly more impairment in group C compared to group B (p=0.01), and to A (p<0.001). Other QoL items were similar among age groups (table 1) . During follow up, the decline in QoL was similar between the three age groups. Median survival was 35, 27 and 27 weeks for increasing age groups (p=0.05). Although elderly patients tended to respond less to radiation therapy compared to younger patients, there was still a significant response: C (67%) compared to A (78%, p=0.07), and to B (74%, p=0.36). No differences in mean time to response or between treatment arms were seen. In multivariate analysis, only primary tumor and performance score were significantly associated with response.
Conclusions:
Although at baseline elderly patients had a higher activity level impairment, and a worse performance score when compared to younger patients, they did not evaluate their overall QoL as inferior. Moreover, the majority of elderly patients showed a meaningful response to radiotherapy for painful bone metastases. Therefore, palliative radiotherapy should be considered in elderly patients.
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New molecular markers for prediction and prognosis ñ ready for personalised therapy? M.E. Hegi 1 1 Centre Hospitalier Univ. Vaudois, Clinical Neurosciences, Lausanne, Switzerland In recent years we have made remarkable progress in molecularly characterizing glioma uncovering their patho-genetic evolution and classifying them into different subtypes. Some of these molecular markers have been recognized to improve diagnostic precision and have a prognostic or even a predictive value for patient management based on retrospective analysis of clinical trials. Among these markers are mutations in the isocitrate dehydrogenase (IDH) 1 or 2 gene that
